X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com//news-release/2023/12/04/2789958/0/en/Acino-completes-acquisition-of-M8-Pharmaceuticals-significantly-expanding-presence-and-capabilities-in-Latin-America.html
https://www.prnewswire.com/news-releases/ucb-presents-new-data-about-the-real-world-experience-of-fintepla-fenfluramine-and-rare-epilepsy-syndromes-at-2023-american-epilepsy-society-aes-annual-meeting-302002158.html
https://www.prnewswire.com/news-releases/ucb-announces-fintepla-fenfluramine-oral-solution-is-now-descheduled-and-is-no-longer-listed-as-a-controlled-substance-301798777.html
https://www.europeanpharmaceuticalreview.com/news/177782/chmp-recommends-fenfluramine-for-lgs-associated-seizures/
https://www.prnewswire.com/news-releases/epilepsia-publishes-interim-results-of-open-label-extension-study-of-fintepla-fenfluramine-oral-solution-in-patients-with-lennox-gastaut-syndrome-lgs-301685487.html
https://www.pharmatimes.com/news/nice_recommends_ucbs_fintepla_for_dravet_syndrome_1449479
https://www.europeanpharmaceuticalreview.com/news/170971/fenfluramine-found-effective-in-preventing-drop-seizures-from-lgs/
https://www.prnewswire.com/news-releases/capable-health-raises-6m-to-underpin-the-next-revolution-in-us-healthcare-301537427.html
https://pharmaphorum.com/news/ucb-takes-on-jazz-in-severe-epilepsy-with-new-fintepla-approval/
https://www.globenewswire.com/news-release/2022/03/04/2397124/0/en/Zogenix-To-Present-New-Long-term-Data-on-FINTEPLA-fenfluramine-in-Lennox-Gastaut-Syndrome-LGS-at-AAN-2022.html
https://www.globenewswire.com/news-release/2021/12/20/2355192/0/en/Zogenix-Submits-Type-II-Variation-Application-to-the-European-Medicines-Agency-EMA-to-Expand-the-Use-of-FINTEPLA-Fenfluramine-for-the-Treatment-of-Seizures-Associated-with-Lennox-G.html
https://www.globenewswire.com/news-release/2021/09/28/2304386/0/en/Zogenix-Submits-Supplemental-New-Drug-Application-for-FINTEPLA-Fenfluramine-for-the-Treatment-of-Seizures-Associated-with-Lennox-Gastaut-Syndrome.html
https://www.globenewswire.com/news-release/2021/08/26/2287018/0/en/Zogenix-Receives-Orphan-Drug-Designation-for-FINTEPLA-Fenfluramine-in-Japan.html
https://zogenixinc.gcs-web.com/news-releases/news-release-details/zogenix-launches-global-access-program-finteplar-fenfluramine#:~:text=Zogenix%20Launches%20Global%20Access%20Program%20for%20FINTEPLA%C2%AE%20(Fenfluramine)%20Oral%20Solution,-04.27.21&text=FINTEPLA%20is%20approved%20in%20the,aged%20two%20years%20and%20older.
http://www.pharmafile.com/news/567148/zogenix-gets-eu-marketing-authorisation-anti-seizure-drug
http://www.pharmatimes.com/news/eu_green_light_for_zogenixs_fintepla_1360479
http://www.pharmafile.com/news/567148/zogenix-gets-eu-marketing-authorisation-anti-seizure-drug
http://www.pharmatimes.com/news/eu_green_light_for_zogenixs_fintepla_1360479
https://seekingalpha.com/news/3616308-zogenix-proposes-200m-debt-offering
https://seekingalpha.com/news/3612878-zogenixs-fintepla-successful-in-third-pivotal-study-in-severe-type-of-epilepsy
https://www.raps.org/news-and-articles/news-articles/2020/7/fda-approvals-roundup-fintepla-dojolvi-phesgo
https://www.fda.gov/news-events/press-announcements/fda-approves-new-therapy-dravet-syndrome#:~:text=The%20FDA%20granted%20approval%20of,human%20use%2C%20and%20medical%20devices.
https://endpts.com/so-close-yet-so-far-zogenix-lgs-trial-succeeds-but-results-underwhelm/
https://zogenixinc.gcs-web.com/news-releases/news-release-details/zogenix-announces-positive-top-line-results-global-pivotal-phase
https://www.globenewswire.com/news-release/2019/12/18/1961939/0/en/The-Lancet-Publishes-Phase-3-Trial-Results-for-Zogenix-Investigational-Drug-FINTEPLA-in-Dravet-Syndrome.html
https://www.reuters.com/article/us-servier-mediator-trial/french-weight-loss-pill-scandal-set-for-landmark-trial-idUSKBN1W51BY
https://www.fiercebiotech.com/biotech/zogenix-plunges-after-fda-spurns-filing-for-rare-epilepsy-drug
https://endpts.com/on-the-heels-of-gws-epilepsy-win-wall-street-darling-zogenix-shares-positive-phiii-data-on-rival-drug/
https://www.forbes.com/sites/mikeadams/2018/07/10/is-dea-being-forced-to-reschedule-the-cbd-compound/#440a7def1810
https://www.fiercebiotech.com/biotech/chasing-gw-zogenix-scores-a-win-second-dravet-phase-3
http://finance.yahoo.com/news/zogenix-receives-orphan-drug-designation-130000447.html
Market Place
Share 
